Eastman Chemical management commentary: Strong additives performance supports Q3 2026 EPS growth

By Public Technologies
  • Eastman Chemical management commentary reported third-quarter 2026 adjusted EPS of $1.84, up significantly year over year but modestly lower sequentially.
  • Revenue fell 5% sequentially as sales volume/mix declined 7%, reflecting seasonal weakness and customer caution.
  • Management attributed the sequential earnings decline primarily to escalating Middle East conflict, which increased costs and weakened demand.
  • Additives & Functional Products earnings exceeded expectations, while Advanced Materials faced softer demand, operational constraints and raw material cost pressures.
  • Management projected full-year 2026 adjusted EPS of $6.00 to $6.20, with operating cash flow of approximately $850 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eastman Chemical Company published the original content used to generate this news brief on October 29, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.